Amulet Capital Partners and Shady Grove Fertility have launched US Fertility, a business support services platform for fertility focused physician practices. No financial terms were disclosed.
Greenwich, CT – May 20, 2020 – Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector, and Shady Grove Fertility (“SGF”), the largest independent fertility practice in the U.S today announced the formation of a business support services platform, US Fertility (“USF”). USF will support fertility focused physician practices with a range of non-clinical services including clinical and business information systems, facilities and operations management, finance and accounting, and fertility treatment financing programs. The USF transaction is the first investment from Amulet Capital Fund II.
As part of the formation of USF, the clinical and practice management software assets of IntegraMed Fertility were acquired. SGF Chief Executive Officer, Mark Segal and the newly appointed CEO of USF commented, “Our purchase of a fully integrated and customized electronic medical record (EMR), practice management, and customer relationship management (CRM) solution provides a foundation to support USF’s partner practices on a go-forward basis as well as enable other practices to receive transitional operational support that is needed at this time.”
Michael Levy, President of SGF, said, “When SGF was founded 29 years ago the goal of the new practice was simple—to provide cutting edge fertility care in an environment that supported patients’ physical, emotional, and financial needs. Today I am incredibly excited to be joining other leading fertility practices across the U.S to form USF, whose scale and breath will only further enhance each partner practices ability to deliver best in class clinical care to patients.”
Dr. Christopher Sipe, Medical Director of Fertility Centers of Illinois remarked, “We firmly believe that physician owned and shared governance practice support models, such as those at USF, best enable local physician practices to meet the needs of their patients while simultaneously benefitting from the support of a national non-clinical support services infrastructure.”
Dr. Louis Weckstein, Medical Director of RSC of the San Francisco Bay Area said, “We are incredibly grateful that USF will be able to provide fertility practices with the necessary stability, leadership and financial support during these incredibly uncertain times caused by the COVID-19 pandemic.”
Dr. Marcelo Barrionue, President of IVF Florida commented, “In order to not only remain viable but to thrive in the rapidly changing fertility environment we are seeing today, practices need the necessary support and resources an organization such as USF provides.”
Jay Rose, Managing Partner at Amulet, remarked, “We are very excited to form USF alongside some of the most highly respected practices across the U.S. Reproductive medicine is an area seeing meaningful innovation in care delivery. One of the goals at USF will be to expand the range of support services available to our physician partner practices so they can continue to meet increasing patient demands for fertility services.”
Terms of the transaction were not disclosed.
SGF has been a pioneer and leader in advancing the field of reproductive medicine for nearly 3 decades through its commitment to providing comprehensive, accessible and affordable patient-centered care, investment in clinical research, and education of the next generation of reproductive endocrinologists via two fellowship programs. SGF is home to more than 85,000 babies born and the largest physician referral network in the nation. SGF’s 61 physicians have served patients from all 50 states and 40 countries around the world with 38 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile. Call 1-888-761-1967 or visit ShadyGroveFertility.com.
About Amulet Capital Partners, LP
Amulet Capital Partners, LP is a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector. Amulet seeks to achieve long-term capital appreciation through privately negotiated investments in companies. Amulet Capital Partners focuses on those segments it believes have the most attractive long-term fundamentals with a target investment size generally between $25 million to $150 million. For additional information, please visit www.amuletcapital.com.